Gene Query: LMAN1

Dataset Description Geneva Score
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 102.79
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 102.79
Differentially expressed genes post knock down of lincDUSP26 75.31
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 65.25
Differetially expressed genes after hTR overexpression in U2OS cells 44.13
The effect of Foxc1 deficiency on undifferentiated and differentiated human primary keratinocytes 43.68
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 43.24
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 40.9
Sensing self and nonself circular RNAs 38.17
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 35.05
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 34.97
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 32.98
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 32.98
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 30.14
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 30.11
RNA-seq of human aneuploid cell lines with Trisomy 21 28.83
Small extracellular vesicles are key regulators of non-cell autonomous intercellular communication in senescence via the interferon protein, IFITM3 28.67
SF3B1 Degron knockdown RNA-seq 28.54
Next Generation Sequencing Facilitates Quantitative Analysis of ALDH+ E-BCSC, CD24-CD44+ M-BCSC and Bulk tumor cell Transcriptomes from MC1 and Vari068 PDX models of TNBC 28.07
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 28.04
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 27.52
Allogeneic mature human dendritic cells generate superior alloreactive regulatory T cells in the presence of IL-15 27.48
Electronic cigarettes 27.21
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 27.08
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 24.96
Simultaneous and systematic analysis of cellular and viral gene expression during Enterovirus 71-induced host shutoff 24.64
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 24.6
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 24.59
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells 24.45
Human cell line and subcutaneous tumor 23.26
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 23.19
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 22.95
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 22.93
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 21.68
Developmental stage specific chromosome architecture in human erythroid cells 21.68
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 21.36
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 21.2
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 21.2
Modeling Familial Cancer with iPSC Approaches 21.19
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 21.09
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 21.09
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 20.3
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 20.04
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 20.01
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 19.53
Global expression profiles in cardiac progenitor cells generated by ISX-9 19.51
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 19.51
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 19.51
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 19.38
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 19.15
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 19.1
Molecular mechanism underlying increased ischemic damage in the ALDH2*2 genetic polymorphism using a human iPSC model system 19.06
The regulartory role of ZCCHC24 in splicing machinery 19.04
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 18.77
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 18.73
FUS mutant human motoneurons transcriptome analysis reveals altered pathways and impairment of microRNA function 18.69
Human serum and heparin-free platelet lysate as appropriate xeno-free alternatives for production of human MuStem cell batches 18.48
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 18.24
Transcriptomes of human monocytes and monocyte-derived macrophages with or without glucocorticoid treatment 18.21
Genes significantly down or Up-regulated upon RNF219 knockdown 18.04
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 18.0
Cleavage Factor Im as a key regulator of 3’ UTR length 17.98
Co-transcriptional loading of RNA export factors shapes the human transcriptome 17.6
RNAseq of HEK293 cells after Chtop knockdown 17.6
Effect of BRCA1 overexpression on genetic expressions of cervical cancer based on next generation sequencing 17.29
Identifying the molecular mode of action of itraconazole in colorectal cancer 17.22
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 17.08
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 16.91
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 16.91
An optimization system for isolating and sequencing of single human colon cancer cells 16.8
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 16.78
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 16.76
Restoration of Progranulin Expression Rescues Cortical Neuron Generation in Induced Pluripotent Stem Cell Model of Frontotemporal Dementia 16.7
Genome-wide expression profiling of B Lymphocytes reveals IL4R increase in allergic asthma 16.48
Telomere-Dependent and Telomere-Independent Roles of RAP1 in Regulating Human Stem Cell Homeostasis 16.44
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 16.01
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 15.91
Next generation sequencing of human hepatic stellate cell line, LX-2 treated with recombinant human TGF-β1, with DMSO or ML290 (5 µM) for 72h. 15.87
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 15.77
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 15.66
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 15.66
RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids 15.6
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 15.58
Analysis of MGE Transcriptomes with or without Ctnnb1 knockout in human through RNA Sequencing 15.48
RNA-Seq with and without RNase treatment in PCa cell lines 15.37
Transcriptome Profiling of Human Primary Monocytes 15.35
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state 15.29
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 15.25
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 15.25
Nm-seq finds thousands of modified 2’-O-methylation sites in mRNA with base precision 15.18
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 15.1
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 15.06
Landscape of H3K4me3 in human CD19 cells 14.95
The contribution of Alu exons to the human proteome 14.9
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 14.72
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 14.56
A transcriptional regulatory network connects mitochondrial biogenesis and metabolic shift with stem cell commitment to hepatic differentiation 14.53
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 14.47
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 14.39
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 14.39
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 14.34
An RNA-centric dissection of host complexes controlling flavivirus infection 14.34
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 14.25
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 14.25
RNA m5C Methylation in breast cancer using MeRIP-Seq 13.97
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 13.85
RNA-seq of Human neck of femur (NOF) fracture hip and osteoarthritic (OA) cartilage 13.83
Long noncoding RNA ROCR contributes to SOX9 expression and chondrogenic differentiation of human mesenchymal stem cells 13.83
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 13.8
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 13.76
Reassessment of Exosome Composition 13.62
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 13.61
High-throughput sequencing of PROMPT-enriched samples. 13.61
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 13.59
EP400 is required for Max and MCPyV mediated gene activation 13.31
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 13.3
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 13.15
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 13.13
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 13.06
Regulation of highly expressed hCINAP on translatome 13.05
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 13.0
Safeguarding nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis 12.83
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 12.72
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 12.72
Large-scale expansion of human iPSC-derived skeletal muscle cells for disease modeling and cell-based therapeutic strategies 12.67
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 12.66
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 12.64
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 12.58
FOXA1 Chromatin Binding is Regulated by LSD1-Mediated Demethylation 12.56
RNA-Seq with DHT induction and/or GSK treatment at 24, 48 hrs and 2 weeks 12.56
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 12.54
Genome-wide expression profiling of an in vitro model for studying esophageal epithelial differentiation 12.48
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 12.42
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 12.41
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 12.38
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 12.36
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 12.36
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 12.34
3’ Uridylation Expands miRNA Target Repertoire 12.25
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma (RNA-seq) 12.22
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma 12.22
RNA-Seq analysis of breast cancer cells after shikonin treatment 12.22
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 12.15
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 12.15
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 12.09
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 12.03
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 12.01
PTEN suppresses neoplastic transformation of human neural stem cells by transcriptional repression of Pax7 11.97
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 11.96
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 11.95
RNA-seq analyses of human prostate cancer cells 11.91
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 11.86
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 11.75
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 11.74
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 11.7
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 11.69
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 11.66
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 11.66
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 11.63
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 11.62
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 11.54
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 11.54
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 11.53
Global Mapping of Human RNA-RNA Interactions 11.48
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 11.42
Expression by CD133+ cells isolated from the adult human exocrine pancreas 11.41
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 11.4
RNA-seq of shEZH2 cells 11.3
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 11.26
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 11.19
A prostate cancer chromatin interaction map 11.17
Ribosomal footprinting of MDA-Parental and MDA-LM2 11.08
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 10.94
DJ-1 is dispensable for human stem cell homeostasis 10.88
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 10.86
RNA-seq and Microarray in Transcriptome Profiling of Anterior Cruciate Ligament Tears: Implications for Prognostic Biomarkers Discovery 10.84
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation 10.78
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines (mRNA-Seq) 10.74
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines 10.74
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression 10.72
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 10.69
Knockdown of FOXP1 promotes the development of lung adenocarcinoma 10.68
Gene expression changes associated with resistance to tagraxofusp (SL-401) 10.65
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 10.63
hTERT promotes cell adhesion and migration independent of telomerase activity 10.6
Lipid degradation promotes prostate cancer cell survival 10.58
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 10.54
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 10.47
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 10.43
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 10.36
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 10.36
Exploring the RNA landscape of endothelial exosomes 10.35
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 10.31
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 10.24
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 10.23
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 10.21
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 10.19
Role of XRN2 ribonucleolytic activity in RNA metabolism 10.16
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 10.15
Survival of pancreatic cancer cells lacking KRAS function 10.14
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 10.1
AhR activity directs BRAF inhibitors resistance in metastastic melanoma 10.08
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 10.08
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 10.07
Crizotinib v. DMSO in SW480 cells 10.04
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 10.03
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 10.02
Chemical Enhancement of Direct Cardiac Reprogramming In Vitro and In Vivo 10.0
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 9.99
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 9.9
Transcriptomic analysis of the HOTAIR-regulated genes 9.89
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 9.87
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 9.84
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 9.84
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 9.83
Human cells contain natural double-stranded RNAs with potential regulatory capacity 9.82
Be1 and Be2 B cells are transcriptionally distinct 9.79
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 9.78
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 9.72
RNA-sequencing of human tendon after injury 9.7
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 9.65
The interplay between SOX4 and SMAD3 in the context of breast cancer 9.62
Mapping interactions for the TNIP2 hub protein 9.61
Macrophage Ad5f35 M2 Challenge 9.6
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 9.58
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 9.53
Gene expression signatures of innate lymphoid cells from human blood 9.51
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 9.51
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 9.48
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 9.48
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 9.47
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 9.44
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 9.42
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA 9.41
Determination of tRNA aminoacylation levels by high throughput sequencing 9.35
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 9.32
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 9.32
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 9.24
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 9.21
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 9.21
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates 9.19
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 9.17
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 9.17
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 9.17
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 9.17
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 9.11
Genome-wide analysis of ferroptosis related genes in liver cancer cells. 9.06
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 8.98
scRNASeq analysis of cycling cardiomyocytes 8.98
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 8.89
Systematic discovery of endogenous human ribonucleoprotein complexes 8.88
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 8.85
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 8.76
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 8.76
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 8.68
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 8.63
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 8.57
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest 8.57
Decrease in EZH2 histone methyltransferase mediates the effects of fluid shear stress (FSS) in endothelial cells 8.56
Next Generation Sequencing Facilitates Quantitative Analysis of mesoderm posterior bHLH transcription factor 1(MESP1)+ and MESP1- cells' Transcriptomes 8.4
Transcript abundance in A-T-derived iPSC: Comparing isogenic cells to unrelated individual 8.39
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 8.28
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 8.27
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 8.19
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 8.16
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 8.12
RNA sequencing of prostate cancers reveal insights on the prognostic significance of visibility on multi-parametric MRI 8.09
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 8.05
Studying iPSCs from a hibernating mammal reveals molecular mechanisms of cold resistance in neural tissues 8.04
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture 7.98
Effect of ILF3 on translation during homeostasis and the antiviral response 7.95
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 7.93
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 7.89
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 7.86
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 7.76
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 7.76
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 7.76
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 7.75
Molecular Criteria for Defining the Naive Human Pluripotent State 7.66
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 7.64
Functional Cardiac Fibroblasts Derived from Human Pluripotent Stem Cells via Second Heart Field Progenitors 7.62
Induced DNA demethylation, genome instability and transcription 7.58
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 7.58
Regulatory network controlling tumor-promoting inflammation in human cancers 7.5
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 7.5
RNA-sequencing in irradiated and normal A549 cells. 7.47
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 7.46
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 7.43
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 7.42
Gene Expression Profiling of WT and KDM3A Knocked out Cell 7.37
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 7.37
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] 7.26
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL 7.26
CRIG identifies a novel population of highly phagocytic peritoneal macrophages associated with disease severity in patients with cirrhosis and ascites 7.23
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 7.13
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 6.99
Gene expression in skeletal muscle in older individuals subject to ten days of complete bed rest. 6.75
BACH2 in human plasma cell fate decision 6.64
Apolipoprotein E4 Expression Causes Gain of Toxic Function in Isogenic Human Induced Pluripotent Stem Cell-Derived Endothelial Cells 6.49
ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin 6.42
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 6.41
Wide-spread disruption of transcription termination in HSV-1 infection: Next-generation sequencing of translational activityd by ribosome profiling 6.4
MEK inhibition rewires enhancer landscapes in RAS-driven Rhabdomyosarcoma to unlock a myogenic differentation block 6.24
Epigenetic Reprogramming of mutant RAS-driven Rhabdomyosarcoma via MEK Inhibition 6.24
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 6.23
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 6.21
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 6.18
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 6.18
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 6.11
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 6.06
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 6.06
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 6.05
Regulating Interleukin-2 activity with engineered receptor signaling clamps 5.99
Profiling of escape kinetics of viruses subjected to RNAi 5.98
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 5.96
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 5.96
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 5.95
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 5.92
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 5.86
RNA transcriptome analysis during HSV-1 infection 5.85
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 5.84
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 5.8
mRNA expression in iPS cells generated by a synthetic self-replicative RNA 5.79
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 5.71
Induction of Sertoli-like cells from human fibroblasts by NR5A1 and GATA4 5.67
Exploring ILF2 regulatory genes by next-generation sequencing 5.65
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 5.59
Aneuploidy-induced cellular stresses limit autophagic degradation. 5.57
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 5.45
Gene Expression Profiling of SPOP Knocked Down Cell 5.43
Metastasis in triple-negative breast cancer 5.4
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 5.4
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 5.4
ETS1 acts as a tumor suppressor in breast cancer by inhibiting growth-related factors 5.4
Serotonin-induced hyperactivity in SSRI-resistant major depressive disorder patient-derived neurons 5.38
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 5.29
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 5.28
RNA expression analysis upon JMJD1C depletion 5.28
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 5.26
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 5.14
Transcriptome analysis of kidney organoids 5.09
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 5.09
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 5.08
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 5.02
A novel non-canonical signaling pathway mediates TGF-β1-induced glucocorticoid insensitivity in epithelial cells 4.89
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 4.89
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 4.84
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 4.81
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 4.81
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 4.77
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 4.77
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [H1 RNA-seq] 4.72
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 4.72
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 4.72
RNA-Seq of PRMT1 overexpression ECA109 cells 4.64
Gene expression regulated by CSA and CSB in neuroblastoma cell line 4.58
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 4.57
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 4.56
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 4.56
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 4.55
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 4.44
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 4.33
COMBINING BET AND MEK INHIBITORS SYNERGISTICALLY TARGETS NRAS MUTANT MELANOMA 4.22
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 4.2
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 4.13
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 4.13
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 4.11
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 4.07
Alagille_Nodder 4.07
RNA Seq of Alagille liver biopsies 4.07
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 4.06
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 3.96
Transcriptomes of human monocytes after ex vivo exposure to uric acid 3.96
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans 3.89
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans 3.89
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 3.88
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 3.86
Copper Regulation of HIF-1 Transcription Activity 3.77
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 3.77
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 3.72
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 3.7
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 3.63
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 3.6
Interaction between mitoNEET and NAF-1 in cancer cells 3.51
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 3.5
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 3.48
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 3.48
Human iPSC-derived cells and microengineered Organ-Chip enhance neural development. 3.42
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 3.4
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 3.37
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 3.29
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 3.29
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 3.28
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 3.25
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 3.25
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 3.21
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 3.2
IMP3 regulated gene expression in breast cancer cells 3.2
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines 3.2
Identification of global XBP1s target gene expression in human prostate cancer cells 3.15
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 3.07
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq 2.93
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes 2.93
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 2.88
ADAR1-editing of cellular and measles virus-derived duplex RNA 2.88
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 2.84
Genes encoding cognate receptors for IRI-related recipient cytokines are expressed in donor livers 2.83
SQSTM1/p62-directed metabolic reprogramming is essential for normal neurodifferentiation 2.75
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 2.7
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 2.69
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 2.69
Metabolism as an early predictor of DPSCs aging 2.65
RNA-seq study reveals unique transcriptome expression in systemic lupus erythematosus patients with distinct autoantibody profile 2.64
hiPSCs unravel aberrant TGFβ signaling as an etiology of left ventricular non-compaction 2.57
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 2.53
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 2.52
A transcriptome dataset revealing the molecular features of breast cancer stem cells 2.52
PML2-mediated thread-like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome 2.46
PML2‐mediated thread‐like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome [RNA-seq] 2.46
The transcriptome effect of overexpressing EZH2 in MCF7 2.42
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 2.41
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 2.32
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 2.32
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 2.3
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 2.3
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 2.24
Iron response of HepG2 cells 2.17
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 2.14
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 2.11
Modulation of nonsense-mediated decay by rapamycin 2.1
Acetylation-Dependent Control of Global Poly(A) RNA Degradation by CBP/p300 and HDAC1/2 2.0
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 1.9
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 1.89
RNA-seq of naive and primed ES cells (NHSM) 1.87
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 1.87
Frailty in middle age is associated with race-specific changes to the transcriptome. 1.81
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 1.74
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 1.69
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 1.66
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 1.63
Subcellular pathways shared by afflicted patients and mutant mice identify a new drug treatment for aortic aneurysm in Marfan syndrome 1.62
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 1.61
The mRNA expression analysis of psoriasis skin lesion mesenchymal stem cell 1.6
WNT signaling memory is required for ACTIVIN to function as a morphogen 1.52
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 1.52
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 1.52
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 1.51
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 1.51
Transcriptional landscape changes during human embryonic stem cell derivation 1.49
Interphase condensins regulate ligand-depedent enhancer activation 1.43
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 1.43
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 1.4
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 1.38
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 1.32
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 1.32
Identification of long noncoding RNAs regulated by p53 1.29
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 1.28
Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia and facial dysmorphism 1.07
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_TK] 1.07
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 1.04
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 0.96
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 0.89
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 0.89
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 0.86
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 0.86
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 0.85
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 0.8
RNA sequencing analysis of selumetinib-resistant CRC cells lines 0.74
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 0.71
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 0.67
6mer seed toxicity in viral microRNAs 0.62
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 0.61
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 0.61
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 0.6
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 0.59
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.58
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 0.57
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.56
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.56
Transcriptomic analysis of human coronary artery endothelial cells stimulated with TNF-alpha in the presence and absence of ACSL3 siRNA 0.53
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 0.5
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 0.49
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 0.48
single cell RNA-seq from GM12878 (ENCSR673UIY) 0.48
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 0.47
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 0.46
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 0.45
Dilated cardiomyopathy vs Myocarditis 0.44
Next Generation Sequencing of Lung Primary Fibroblast Responding to Eosinophil-Degranulation Products 0.43
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.43
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.43
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.37
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.22
Kinetics of cytokine receptor trafficking determine signaling and functional selectivity 0.11
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 0.1
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 0.09
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 0.07
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.07
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.03
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation